Lattice Biologics Ltd. (LBLTF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 3, 2025
Lattice Biologics Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | 2015 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '21 Jun 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | Sep '18 Sep 30, 2018 | Sep '17 Sep 30, 2017 | Sep '16 Sep 30, 2016 | 2015 - 2014 |
| Net Income | -0.95 | -1.48 | -1.01 | -1.23 | -1.52 | -7.85 | Upgrade
|
| Depreciation & Amortization | 0.18 | 0.38 | 0.2 | 0.2 | 0.22 | 0.48 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | - | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 0.3 | - | Upgrade
|
| Stock-Based Compensation | - | - | 0.02 | 0.15 | 0.3 | 1.39 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 0.02 | - | - | 0.08 | Upgrade
|
| Other Operating Activities | -0.8 | -0.04 | 0.27 | -0.37 | -2.32 | 1.35 | Upgrade
|
| Change in Accounts Receivable | 0.07 | -0.03 | -0.11 | 0.05 | 0.21 | 0.26 | Upgrade
|
| Change in Inventory | 0.06 | 0.18 | 0.78 | 0.36 | 0.35 | 0.76 | Upgrade
|
| Change in Accounts Payable | 1.28 | 1.5 | 0.04 | 1.21 | 1.71 | 1.61 | Upgrade
|
| Change in Other Net Operating Assets | 0.02 | 0.02 | -0.05 | -0.11 | 0.01 | -0.21 | Upgrade
|
| Operating Cash Flow | -0.13 | 0.54 | 0.16 | 0.26 | -0.75 | -2.13 | Upgrade
|
| Operating Cash Flow Growth | - | 231.72% | -38.80% | - | - | - | Upgrade
|
| Capital Expenditures | -0.57 | -0.59 | -0.05 | -0.23 | -0.03 | -0.05 | Upgrade
|
| Investing Cash Flow | -0.57 | -0.59 | -0.05 | -0.23 | -0.03 | -0.05 | Upgrade
|
| Long-Term Debt Issued | - | 0.32 | - | - | 0.03 | 0.43 | Upgrade
|
| Total Debt Issued | 0.16 | 0.32 | - | - | 0.03 | 0.43 | Upgrade
|
| Long-Term Debt Repaid | - | -0.22 | -0.1 | -0.05 | -0.25 | -0.55 | Upgrade
|
| Total Debt Repaid | -0.11 | -0.22 | -0.1 | -0.05 | -0.25 | -0.55 | Upgrade
|
| Net Debt Issued (Repaid) | 0.05 | 0.1 | -0.1 | -0.05 | -0.22 | -0.13 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 0.55 | 2.31 | Upgrade
|
| Other Financing Activities | - | - | - | - | 0.41 | - | Upgrade
|
| Financing Cash Flow | 0.05 | 0.1 | -0.1 | -0.05 | 0.74 | 2.18 | Upgrade
|
| Net Cash Flow | 0.01 | 0.04 | 0.01 | -0.01 | -0.03 | 0 | Upgrade
|
| Free Cash Flow | -0.7 | -0.06 | 0.11 | 0.03 | -0.77 | -2.18 | Upgrade
|
| Free Cash Flow Growth | - | - | 229.28% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -44.92% | -2.27% | 5.01% | 2.88% | -28.28% | -57.75% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.00 | 0.00 | - | -0.01 | -0.04 | Upgrade
|
| Cash Interest Paid | 0.06 | 0.06 | 0.06 | 0.01 | 0.03 | 0.17 | Upgrade
|
| Levered Free Cash Flow | - | -1.07 | 0.21 | 0.37 | -1.72 | 1.52 | Upgrade
|
| Unlevered Free Cash Flow | - | -0.42 | 0.55 | 0.66 | -1.43 | 2.17 | Upgrade
|
| Change in Working Capital | 1.44 | 1.67 | 0.67 | 1.51 | 2.27 | 2.42 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.